Word: phasing
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Polly Price, Harvard’s associate vice president for human resources, said the HR project was originally slated to run off of software provided by the Oracle Corporation, the vendor that provided the software for the financial systems installed during the first phase of Project ADAPT...
...Bush administration, a source said that she would be kept on at least as long as the trial continued. Guilty verdicts on all 302 counts against the four defendants were handed down May 29, a major coup for White's office. Now the case enters the penalty phase. Two of those convicted, Mohamed Rashed Daoud Al-'Owhali, 24, of Saudi Arabia and Khalfan Khamis Mohamed, 27, of Tanzania, face the death penalty. The process calls for a mini-trial in which prosecutors and defense lawyers will put on witnesses for and against each man. Al-'Owhali's proceedings started Tuesday...
...accused were at best mid-level operatives in his diffuse international network - and therefore easily replaced. In a warrior cult that holds martyrdom as its highest honor, being imprisoned - or even executed, as may be the case for two of the accused when the trial concludes its penalty phase - by the enemy is scarcely a deterrent...
...stage is being set for the next phase in the struggle for the leadership of black America. That struggle began in slavery, when the great abolitionist Frederick Douglass emerged as the first unquestioned spokesman for the African-American agenda. Over the decades, the battle to inherit Douglass's mantle sparked epic struggles, such as the early 20th century clash between the accommodationist Booker T. Washington and W.E.B. Du Bois, the militant founder of the N.A.A.C.P. The most recent chapter played out in the early 1970s, when Jackson himself displaced Martin Luther King Jr.'s closest confidant, Ralph David Abernathy, putting...
...Cambridge, Mass., Millennium Pharmaceuticals is focusing on proteins called proteasomes, which evidently play a role in giving cancer cells unnaturally long lives. The company is in Phase II trials with LDP341, a proteasome-inhibiting substance that is showing promise against multiple myeloma and chronic lymphocytic leukemia. Phase I studies on the top five solid tumors (breast, pancreatic, prostate, lung and colon) are under way, and at this point the inhibitor seems to be working--at least in mice...